on ABIVAX (EPA:ABVX)
ABIVAX: Statement of Share Capital and Voting Rights as of July 31, 2026
ABIVAX, a biotechnology company listed on Euronext Paris, has published its share capital and voting rights figures as of July 31, 2026. ABIVAX's share capital amounts to €872,537.97, divided into 87,253,797 shares. These shares carry a total of 88,512,554 theoretical and exercisable voting rights.
Theoretical voting rights include all shares, including those without voting rights, and serve as the basis for calculating threshold crossings in accordance with AMF regulations. Executable voting rights, on the other hand, exclude these shares without voting rights.
This information falls within the legal framework governing corporate transparency towards financial market participants.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all ABIVAX news